DK1763339T3 - Orale antimikrobielle farmaceutiske præparater - Google Patents

Orale antimikrobielle farmaceutiske præparater

Info

Publication number: DK1763339T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical preparations; antimicrobial pharmaceutical; oral antimicrobial; oral; colon
Prior art date: 2004-06-25

Application number

DK05749954T

Other languages

Danish (da)

English (en)

Inventor

Mauro Aiani

Roberta Bozzella

Giuseppe Celasco

Roberto Villa

Original Assignee

Cosmo Technologies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-25

Filing date

2005-05-03

Publication date

2008-08-11

2005-05-03 Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd

2008-08-11 Application granted granted Critical

2008-08-11 Publication of DK1763339T3 publication Critical patent/DK1763339T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK05749954T 2004-06-25 2005-05-03 Orale antimikrobielle farmaceutiske præparater DK1763339T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT001295A ITMI20041295A1 (it)	2004-06-25	2004-06-25	Composizioni farmaceutiche antimicrobiche orali
PCT/EP2005/052025 WO2006003043A1 (en)	2004-06-25	2005-05-03	Oral antimicrobial pharmceutical compositions

Publications (1)

Publication Number	Publication Date
DK1763339T3 true DK1763339T3 (da)	2008-08-11

Family

ID=34968899

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05749954T DK1763339T3 (da)	2004-06-25	2005-05-03	Orale antimikrobielle farmaceutiske præparater

Country Status (22)

Country	Link
US (9)	US8486446B2 (el)
EP (2)	EP1763339B1 (el)
JP (2)	JP5026262B2 (el)
KR (2)	KR101157486B1 (el)
CN (2)	CN101317826A (el)
AT (1)	ATE392889T1 (el)
CA (2)	CA2569683C (el)
CY (1)	CY1108196T1 (el)
DE (1)	DE602005006278T2 (el)
DK (1)	DK1763339T3 (el)
ES (1)	ES2303255T3 (el)
FI (1)	FIC20190031I1 (el)
HR (1)	HRP20080252T3 (el)
HU (1)	HUS1900037I1 (el)
IT (1)	ITMI20041295A1 (el)
MX (1)	MXPA06014698A (el)
PL (1)	PL1763339T3 (el)
PT (1)	PT1763339E (el)
RS (1)	RS50581B (el)
SI (1)	SI1763339T1 (el)
WO (1)	WO2006003043A1 (el)
ZA (1)	ZA200610577B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2420226B1 (en) †	2007-07-06	2020-03-04	Lupin Limited	Pharmaceutical compositions of rifaximin
WO2009037264A2 (en) *	2007-09-17	2009-03-26	Da Volterra	Colonic delivery of antimicrobial agents
BRPI1006145B8 (pt)	2009-01-12	2021-05-25	Biokier Inc	composição e método para tratamento de diabetes
US9006288B2 (en)	2009-01-12	2015-04-14	Biokier, Inc.	Composition and method for treatment of diabetes
US9314444B2 (en)	2009-01-12	2016-04-19	Biokier, Inc.	Composition and method for treatment of NASH
US20110097401A1 (en)	2009-06-12	2011-04-28	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
WO2011038014A2 (en)	2009-09-23	2011-03-31	Biokier, Inc.	Composition and method for treatment of diabetes
WO2012016707A2 (en) *	2010-08-06	2012-02-09	Ratiopharm Gmbh	Oral dosage form for the modified release of dimebolin
WO2012075015A2 (en) *	2010-11-29	2012-06-07	Dr. Reddy's Laboratories Ltd.	Oral metronidazole pharmaceutical compositions
DK3706724T3 (da)	2017-11-10	2024-10-14	Cosmo Technologies Ltd	Orale rifamycin-sv-sammensætninger
IT202000005782A1 (it)	2020-03-18	2021-09-18	Dpl Pharma S P A	Formulazioni farmaceutiche a rilascio controllato per il trattamento di infezioni intestinali
KR102714380B1 (ko) *	2021-06-09	2024-10-11	강원대학교산학협력단	경구 투여용 나노입자 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE458505B (sv) *	1979-07-10	1989-04-10	Lepetit Spa	Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
US4409209A (en) *	1979-10-12	1983-10-11	Ciba-Geigy Corporation	Novel phosphorylmuramyl peptides and processes for the manufacture thereof
IT1230576B (it) *	1988-10-20	1991-10-28	Angeli Inst Spa	Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
IE61651B1 (en) *	1990-07-04	1994-11-16	Zambon Spa	Programmed release oral solid pharmaceutical dosage form
IT1260505B (it) *	1992-06-01	1996-04-09	Poli Ind Chimica Spa	Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
CN1097306A (zh) *	1993-07-12	1995-01-18	中国医科大学第二临床学院	复方抗炎栓剂
US5849327A (en) *	1994-07-29	1998-12-15	Advanced Polymer Systems, Inc.	Delivery of drugs to the lower gastrointestinal tract
US6861053B1 (en)	1999-08-11	2005-03-01	Cedars-Sinai Medical Center	Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6245351B1 (en)	1996-03-07	2001-06-12	Takeda Chemical Industries, Ltd.	Controlled-release composition
US5985823A (en) *	1997-06-09	1999-11-16	Ambi Inc.	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
KR100446366B1 (ko) *	1997-07-01	2004-09-01	화이자 인코포레이티드	서트랄린 염 및 서트랄린의 서방성 투여형
DE19850445A1 (de) *	1998-11-02	2000-05-04	Falk Pharma Gmbh	Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9910773D0 (en) *	1999-05-11	1999-07-07	West Pharm Serv Drug Res Ltd	Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
JP4790950B2 (ja) *	1999-06-14	2011-10-12	コスモ・テクノロジーズ・リミテッド	制御放出および味感遮蔽経口医薬組成物
JP4393098B2 (ja)	2002-06-21	2010-01-06	独立行政法人科学技術振興機構	アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
CN1201736C (zh) *	2002-07-19	2005-05-18	安徽省药物研究所	甲硝唑结肠定位缓释制剂
AU2003260736B8 (en) *	2002-08-26	2009-04-23	S.L.A. Pharma Ag	A pharmaceutical composition
WO2005030173A1 (en)	2003-09-25	2005-04-07	Ranbaxy Laboratories Limited	Colon-specific drug delivery using interpolymer complexations

2004
- 2004-06-25 IT IT001295A patent/ITMI20041295A1/it unknown
2005
- 2005-05-03 EP EP05749954A patent/EP1763339B1/en active Active
- 2005-05-03 MX MXPA06014698A patent/MXPA06014698A/es active IP Right Grant
- 2005-05-03 DE DE602005006278T patent/DE602005006278T2/de active Active
- 2005-05-03 KR KR1020067027024A patent/KR101157486B1/ko active IP Right Grant
- 2005-05-03 US US11/571,044 patent/US8486446B2/en active Active
- 2005-05-03 PT PT05749954T patent/PT1763339E/pt unknown
- 2005-05-03 CA CA2569683A patent/CA2569683C/en active Active
- 2005-05-03 CN CNA2008101001129A patent/CN101317826A/zh active Pending
- 2005-05-03 SI SI200530254T patent/SI1763339T1/sl unknown
- 2005-05-03 PL PL05749954T patent/PL1763339T3/pl unknown
- 2005-05-03 DK DK05749954T patent/DK1763339T3/da active
- 2005-05-03 KR KR1020087012947A patent/KR20080059337A/ko not_active Application Discontinuation
- 2005-05-03 WO PCT/EP2005/052025 patent/WO2006003043A1/en active Application Filing
- 2005-05-03 JP JP2007517234A patent/JP5026262B2/ja active Active
- 2005-05-03 CN CN2005800206291A patent/CN1976685B/zh active Active
- 2005-05-03 EP EP07122775A patent/EP1894560A1/en not_active Withdrawn
- 2005-05-03 CA CA002628005A patent/CA2628005A1/en not_active Abandoned
- 2005-05-03 RS RSP-2008/0241A patent/RS50581B/sr unknown
- 2005-05-03 AT AT05749954T patent/ATE392889T1/de active
- 2005-05-03 ZA ZA200610577A patent/ZA200610577B/en unknown
- 2005-05-03 ES ES05749954T patent/ES2303255T3/es active Active
2008
- 2008-02-20 JP JP2008039159A patent/JP2008163038A/ja not_active Withdrawn
- 2008-06-05 US US12/133,568 patent/US20080233193A1/en not_active Abandoned
- 2008-06-09 HR HR20080252T patent/HRP20080252T3/xx unknown
- 2008-07-14 CY CY20081100739T patent/CY1108196T1/el unknown
2012
- 2012-04-19 US US13/451,111 patent/US8263120B2/en active Active
- 2012-08-22 US US13/592,097 patent/US20120316229A1/en not_active Abandoned
- 2012-08-22 US US13/592,088 patent/US8741948B2/en active Active
- 2012-09-14 US US13/616,582 patent/US8529945B2/en active Active
2014
- 2014-08-28 US US14/471,509 patent/US20140370093A1/en not_active Abandoned
2019
- 2019-03-01 US US16/289,748 patent/US20190192441A1/en not_active Abandoned
- 2019-05-28 FI FIC20190031C patent/FIC20190031I1/fi unknown
- 2019-07-08 HU HUS1900037C patent/HUS1900037I1/hu unknown
2020
- 2020-12-07 US US17/114,057 patent/US20210093576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE602005006278T2 (de)	2009-10-08
CA2628005A1 (en)	2006-01-12
US20070248664A1 (en)	2007-10-25
US8529945B2 (en)	2013-09-10
US20080233193A1 (en)	2008-09-25
ATE392889T1 (de)	2008-05-15
RS50581B (sr)	2010-05-07
EP1894560A1 (en)	2008-03-05
WO2006003043A1 (en)	2006-01-12
US20120316229A1 (en)	2012-12-13
US8486446B2 (en)	2013-07-16
US20130004569A1 (en)	2013-01-03
JP2008163038A (ja)	2008-07-17
US20140370093A1 (en)	2014-12-18
CY1108196T1 (el)	2014-02-12
KR20080059337A (ko)	2008-06-26
US20190192441A1 (en)	2019-06-27
KR101157486B1 (ko)	2012-07-09
CA2569683C (en)	2012-04-03
HRP20080252T3 (en)	2008-07-31
PL1763339T3 (pl)	2008-10-31
US20210093576A1 (en)	2021-04-01
ZA200610577B (en)	2008-07-30
SI1763339T1 (sl)	2008-08-31
EP1763339B1 (en)	2008-04-23
CN101317826A (zh)	2008-12-10
ES2303255T3 (es)	2008-08-01
FIC20190031I1 (fi)	2019-05-28
US20120207834A1 (en)	2012-08-16
CN1976685B (zh)	2011-05-18
CN1976685A (zh)	2007-06-06
CA2569683A1 (en)	2006-01-12
DE602005006278D1 (de)	2008-06-05
US8263120B2 (en)	2012-09-11
ITMI20041295A1 (it)	2004-09-25
JP2008503540A (ja)	2008-02-07
MXPA06014698A (es)	2007-03-26
EP1763339A1 (en)	2007-03-21
JP5026262B2 (ja)	2012-09-12
US20120316228A1 (en)	2012-12-13
HUS1900037I1 (hu)	2019-07-29
KR20070028441A (ko)	2007-03-12
US8741948B2 (en)	2014-06-03
PT1763339E (pt)	2008-06-19

Publication	Publication Date	Title
FIC20190031I1 (fi)	2019-05-28	Rifamysiini SV
MY150958A (en)	2014-03-31	Compounds for the treatment of multi-drug resistant bacterial infections
ATE369372T1 (de)	2007-08-15	42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
NO20043702L (no)	2004-12-03	8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
DK1401501T3 (da)	2006-01-09	Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ATE355065T1 (de)	2006-03-15	Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
SE0102315D0 (sv)	2001-06-28	Compounds
NO20054244D0 (no)	2005-09-13	Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel
ATE361084T1 (de)	2007-05-15	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
MX2008001917A (es)	2008-03-26	Mezclas insecticidas, sinergicas.
DK1498411T3 (da)	2013-04-15	Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
NO20063105L (no)	2006-09-13	Anordning og fremgangsmate for administrering av terapeutiske midler
WO2007070052A3 (en)	2009-04-16	Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
ATE537828T1 (de)	2012-01-15	Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
DE60012610D1 (de)	2004-09-09	Selektive antibakterielle Zusammensetzungen
EE200300064A (et)	2004-12-15	Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
WO2004091591A3 (fr)	2004-11-25	Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
DE602005011240D1 (de)	2009-01-08	Landwirtschaftliche desinfizierende Zusammensetzung enthaltend Hypochlorsäure und Streumittel
ATE554753T1 (de)	2012-05-15	2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
DK1666473T3 (da)	2013-03-25	Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
EE200800065A (et)	2008-12-15	Prasoloprimidinoonhendit sisaldav toimeaine eesnrmesuurenemuse rahoidmiseks ja raviks
DK1827496T3 (da)	2011-08-08	Orale behandlingssammensætninger indeholde et antiadhæsionsmiddel, et antibakterielt middel og en inkompatibel forbindelse
ITBO20050416A1 (it)	2006-12-23	Composizione per la cura e/o la prevenzione di attacchi da parte di agenti biologici
WO2004108744A3 (en)	2005-03-24	Azalides and azaketolides having antimicrobial activity
CL2004000753A1 (es)	2005-04-22	Compuestos derivados de oxazolidinona y/o isoxazolina, composicion farmaceutica, procedimiento de preparacion, utiles como antibacterianos.